The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “Significance of FXR agonists in MASLD treatment: a deep dive into lipid alteration by analytical techniques”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2026 |
Javier J. Flores, Elizabeth P. Aguilera. Nuevas terapias para enfermedad hepática por depósito graso/metabólica (MASLD/MASH): resultados clínicos y retos en implementación, Revista del Hospital Italiano de Buenos Aires. 2026; 46: e0001314. https://doi.org/10.51987/Rev.Hosp.Ital.B.Aires.v46i3.1314 |
|
2 |
2026 |
Reda M. Mansour, Sherif S. Abdel Mageed, Akram N. Salah, Gharieb S. El‐Sayyad, Wesam A. Abduljabbar, Walaa A. El‐Dakroury, Ahmed E. Elesawy, Nourhan H. Elshami, Nehal I. Rizk, Osama A. Mohammed, Marwa Yousry A. Mohamed, Ahmed S. Doghish. Guardians at the Interface: Microbiota, Intestinal Barriers, and the Gut–Liver Axis in Liver Health and Disease, Comprehensive Physiology. 2026; 16: e70262. https://doi.org/10.1002/cph4.70262 |
|
3 |
2026 |
Yuqing Shen, Xuan Cai, Huaijun Zheng, Zetong Zheng, Li Wu, Meng Yuan, Xi Jin, Dan Ye, Ye Feng. Hepatic delivery of FXR mRNA via lipid nanoparticles enhances the efficacy of a low-dose FXR agonist in the treatment of MASLD, Nanomedicine: Nanotechnology, Biology and Medicine. 2026; 103036103036. https://doi.org/10.1016/j.nano.2026.103036 |